![免疫應(yīng)答概論課件-2_第1頁](http://file4.renrendoc.com/view/2de466a6a55fd822cdd1a908d0d4cfab/2de466a6a55fd822cdd1a908d0d4cfab1.gif)
![免疫應(yīng)答概論課件-2_第2頁](http://file4.renrendoc.com/view/2de466a6a55fd822cdd1a908d0d4cfab/2de466a6a55fd822cdd1a908d0d4cfab2.gif)
![免疫應(yīng)答概論課件-2_第3頁](http://file4.renrendoc.com/view/2de466a6a55fd822cdd1a908d0d4cfab/2de466a6a55fd822cdd1a908d0d4cfab3.gif)
![免疫應(yīng)答概論課件-2_第4頁](http://file4.renrendoc.com/view/2de466a6a55fd822cdd1a908d0d4cfab/2de466a6a55fd822cdd1a908d0d4cfab4.gif)
![免疫應(yīng)答概論課件-2_第5頁](http://file4.renrendoc.com/view/2de466a6a55fd822cdd1a908d0d4cfab/2de466a6a55fd822cdd1a908d0d4cfab5.gif)
版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報或認(rèn)領(lǐng)
文檔簡介
1、The Immune SystemInnateAntimicrobial PeptidesPhagocytes (Macrophages, PMNs, Monocytes, DCs)Alternative Complement SystemAcquired (Adaptive)-B Lymphocytes Antibody-T Lymphocytes Cytotoxicity “Help” Antibody Cytokine SecretionBDCThe Immune SystemInnateAcquire2 light chains ( or )2 heavy chains (5 isot
2、ypes: IgG, M, A, D, E)2 Binding sites (Divalent)Secreted into circulationBinds Soluble Antigen2 Chains / (95%) or / (5%)1 Binding site (Monovalent)Membrane Bound, Not SecretedBinds Antigen Complexed with MHCZap 70fynlckgezVVCCCH1CH2CH3CH2CH3CH1CLCLVLVLVHVHedzIga/IgbIga/IgbBlk, Fyn or LynB and T Lymp
3、hocyte Antigen ReceptorsBDC2 light chains ( or )2 ChainXPID: X-linked polyendocrinopathy, immune dysfunction and diarrheaXLAAD: “Autoimmunity Allergic Dysreg”Scurfin gene (Foxp3/JM2)Immunopathogenesis: Th2 Cytokines, abnormal activation (Il-4,5,13)-Scurfy+Nude: No Autoimmunity-CD4+ into Nude: Diseas
4、e-Bone Marrow into irradiated: No Disease-Require Antigen Stimulation for Disease-Mixed Chimera: No DiseaseBDCXPID: X-linked polyendocrinopaHuman Leukocyte Antigenhuman MHCcell-surface proteinsimportant in self vs. nonself distinctionpresent peptide antigens to T cellsCLASS I: A,B,CCLASS II: DR,DQ,D
5、PHLAJ. NobleHuman Leukocyte AntigenCLASS IThe Human Leukocyte Antigen Complex (6p21.31)DP DQ DR B C AClass II (1.1 Mb)Class IIIClass I (2.2Mb)Complement and CytokinesClass I-like genesand pseudogenesFrequent Recombination Recombinationis RareTelomereCentromere Recombinationis Rare(0.7Mb)BDCThe Human
6、 Leukocyte Antigen Coa3b2a1a2a1a2b1b2Binds 8-10mersExpressed on most Nucleated cellsPresents Cytosolic Proteins to CD8+ T cellsBinds 13-25mersExpressed on APCs, Macs, B cells, activated T cellsPresents Vesicular Proteins to CD4+ T cellsClass IClass IIHLA Class I and II Molecules Have a Distinct Stru
7、cture and FunctionBDCa3b2a1a2a1a2b1b2Binds 8-10mers0501 02010301 0302 ciscisDQA1 DQB1transDQA1*0301/DQB1*0201DQA1*0501/DQB1*0302DQA1*0501/DQB1*0201DQA1*0301/DQB1*0302MaternalPaternalCis and Trans- Class II DimerizationBDC0501 0201030DQB1*0402Asp57Leu56 -chain-chainBDCBDCDQB1*0402Asp57Leu56 -chainHLA
8、-Peptide: TCRCDR1CDR2CDR3CDR3CDR2CDR1NH3+COO-TCRalphaTCRbeta2 Helix1 HelixBDCHLA-Peptide: TCRCDR1CDR2CDR3CDCo-Stimulation TCellAPCCTLA-4 -CD28 +CD154(CD40L)CD2CD58CD40B7(+)IL-1, IL-6, TNFIL-10TGF(-)TCR-MHCBDCCo-Stimulation TAPCCTLA-4 -CAbsence of Signal 2ActivationClonal Anergy or DeletionTCRMHCAPCT
9、oleranceT CellTCRMHCAPCSignal 1 + Signal 2B7T CellcytokinesCD28The 2-Signal Model of Lymphocyte ActivationBDCAbsence of Signal 2ActivationCMHC/self-peptideCD4MHC/VbCD4CD4+ Vbx T cell APCActivated autoreactive CD4+TCR Vbx TH1 cell TCR VbxTCR Vbx(1) expansion of CD4+, autoreactive TH1 cells specific f
10、or autoantigens(2) migration and infiltration of these self reactive CD4+ TH1 cells into tissues and induction of inflammation and autoimmunity(3) induction of regulatory cells which control the growth and activation of the pathogenic autoreactive repertoire of CD4+ T cellsInduction of CD4+ TH1 medi
11、ated autoimmunity:A paradigm for the pathogenesis of rheumatoid arthritis, multiple sclerosis and type I diabetesL. Chess 2002MHC/self-peptideCD4MHC/VbCD4CDTH1 CD4+ cellsTH2 CD4+ cells CD8 or CD4 suppressor precursorCD8 or CD4 suppressor effectorActivated CD4 T cellspeptide/APC Regulatory immunityCD
12、4/CD8 interactions(- )(- )The Control of Activated CD4+ T Cells by Regulatory T cellsApoptosisResting CD4 T cellsIL-12/IFN-gIL-4NKT cells/ CD4+CD25+ cellsCD4+CD25- cells(- )(- )IL-10IFN-gL. Chess 2002TH1 CD4+ cellsTH2 CD4+ cells CT cell activation is regulated by signals derived from the TCR /CD3/CD
13、4 complex and the CD40L and CD28/CTLA-4 co-stimulatory molecules gedzzCD3MHC class II a,b TCRhhPeptide antigenCD4+ T Cell Antigen Presenting Cell (APC)VaVbCaCbCD4Antigen specific TCR signalsCD40CD40LsignalCD28/CTLA-4CD80 (B7.1)/CD86 (B7.2)lckCo-stimulatory signals(- ) / +L. Chess 2002T cell activati
14、on is regulatedgedVaCaCbVbzzp56 lck peptideCD3CD28CD40LFA-3LFA-1ICAM-1MHC IIB7CD40LCD4CD45TCRCD2CD4+ T CellAPC/ B cellhhMolecular Interactions of Helper T Cells and APCB7CTLA-4VLA-1CollagenCD80/CD86L. Chess 2002gedVaCaCbVbzzp56 lck peptidMHC/peptideTCRQa-1/VbActivated CD4+ T cellRestingCD4+ T cellDo
15、wn-regulation of Activated CD4+ T CellsT cell activation induces expression of functional T cell surface molecules Regulatory CD8+ T cellTCR (anti-Qa-1/Vb) Activated CD8+ T cell(+)(-)TCRAPCTCRLate Activated CD4+ T cellVLA-1CollagenCD40LMigration of sites of inflammationInduction and activation of B
16、cells APCsCD25L. Chess 2002MHC/peptideTCRQa-1/VbActivatedActivated TH1 CD4+ T CellCD4+ Cell(TH2 )CD4+ Cell(TH0 )DR3, DR4,DQ8/insulin peptide CD2Macrophage/dendritic cellFc R IFN-g IL-12CD40LCD40a,b, TCRIL-1, TNF, LT, NO, PGE-2B Cell?anti-insulin, GAD ab anti-MogIL-4Immunopathophysiology of Diabetes?
17、Antibody mediated injuryDendritic cell/APCCD40LIL-4CD40LCD8+ CTLFasLperforinb cell deathb islet cellsL. Chess 2002Activated TH1 CD4+ T CellCD4+ Innate Immune System: Toll-like receptor activation of APC T CellCD28B7TCR-MHCLPSToll Like Receptor(pattern Recognition R)IL-1,6,12“Signal 3”Signal 2Signal
18、1Anitgen Presenting Cell (APC)BDCInnate Immune System: Toll-likTh1 vs. Th2 CD4 T CellsTh1IL-12 for differentiationCytokines:Interferon-Interleukin-2Intracellular Pathogens CD8 CytotoxicityDelayed Type HypersensitivityMacrophage ActivationTh2IL-4 for differentiationCytokines:Inerluekin-4Interleukin-5Interluekin-13Extracellular PathogensB Cell activation & IgEImmunoglobu
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025年度養(yǎng)老服務(wù)業(yè)委托貸款協(xié)議
- 自愿合伙經(jīng)營合同書(33篇)
- 2025屆柳州市高三語文下學(xué)期開學(xué)考試卷附答案解析
- 5萬噸年鋰電池物理法循環(huán)再生項目可行性研究報告模板-立項備案
- 2024-2025學(xué)年安徽省滁州市定遠(yuǎn)英華中學(xué)高二上學(xué)期期中考試歷史試卷
- 2025年企業(yè)租賃辦公地點合同標(biāo)準(zhǔn)格式
- 2025年移動支付行業(yè)策劃發(fā)展聯(lián)盟合作協(xié)議模板
- 2025年化妝專業(yè)學(xué)員培訓(xùn)協(xié)議
- 2025年腳踏自行車及其零件項目提案報告模板
- 2025年制造業(yè)轉(zhuǎn)讓合同范文
- 電流互感器試驗報告
- 蔣中一動態(tài)最優(yōu)化基礎(chǔ)
- 華中農(nóng)業(yè)大學(xué)全日制專業(yè)學(xué)位研究生實踐單位意見反饋表
- 付款申請英文模板
- 七年級英語閱讀理解10篇(附答案解析)
- 抖音來客本地生活服務(wù)酒旅商家代運(yùn)營策劃方案
- 鉆芯法樁基檢測報告
- 無線網(wǎng)網(wǎng)絡(luò)安全應(yīng)急預(yù)案
- 國籍狀況聲明書【模板】
- 常用保潔綠化人員勞動合同范本5篇
- 新高考高一英語時文閱讀
評論
0/150
提交評論